Plain-English translation of NCT05010902 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows women with multiple sclerosis or clinically isolated syndrome through pregnancy. Researchers will collect information about how pregnancy affects disease activity, symptoms, and imaging findings to help understand the relationship between pregnancy and MS progression.
Multiple sclerosis most often affects women during their childbearing years, but there is limited information about how pregnancy influences the disease course and what outcomes to expect. This study aims to fill that gap by systematically tracking pregnant women with MS to provide better guidance for patients and doctors.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be followed throughout your pregnancy and after delivery with regular visits to a study clinic. During these visits, your doctor will collect information about your MS symptoms, do blood tests, and perform MRI brain scans to monitor your disease. The study will track how your MS changes during and after pregnancy and collect information about your pregnancy outcome.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
Germany
Enrollment target
~100 participants
Started
January 2013
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 50 Years
Sex
Female only
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nadja Siebert, MD
Experimental & Clinical Research Unit, Charité Universitätsmedizin Berlin
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.